References
- Filkins K, Koos BJ. Ultrasound and fetal diagnosis. Curr Opin Obstet Gynecol 2005;17:185–95
- Halscott TL, Ramsey PS, Reddy UM. First trimester screening cannot predict adverse outcomes yet. Prenat Diagn 2014;34:668–76
- Poon LC, Nicolaides KH. First-trimester maternal factors and biomarker screening for preeclampsia. Prenat Diagn 2014;34:618–27
- Kumar M, Gupta U, Bhattacharjee J, et al. Early prediction of hypertension during pregnancy in a low-resource setting. Int J Gynaecol Obstet 2016;132:159–64
- Huynh L, Kingdom J, Akhtar S. Low pregnancy-associated plasma protein A level in the first trimester. Can Fam Phys 2014;60:899–903
- Baer RJ, Currier RJ, Norton ME, et al. Obstetric, perinatal, and fetal outcomes in pregnancies with false-positive integrated screening results. Obstet Gynecol 2014;123:603–9
- Goetzl L. Adverse pregnancy outcomes after abnormal first-trimester screening for aneuploidy. Clin Lab Med 2010;30:613–28
- Brameld KJ, Dickinson JE, O'Leary P, et al. First trimester predictors of adverse pregnancy outcomes. Aust N Z J Obstet Gynaecol 2008;48:529–35
- Lovgren TR, Dugoff L, Galan HL. Uterine artery Doppler and prediction of preeclampsia. Clin Obstet Gynecol 2010;53:888–98
- Snijders RJM, Thom EA, Zachary JM, et al. First-trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique. Ultrasound Obstet Gynecol 2002;19:353–9
- Doubilet PM. Ultrasound evaluation of the first trimester. Radiol Clin N Am 2014;52:1191–9
- Bromley B, Shipp TD, Lyons J, et al. Detection of fetal structural anomalies in a basic first-trimester screening program for aneuploidy. J Ultrasound Med 2014;33:1737–45
- De Biasio P, Siccardi M, Volpe G, et al. First-trimester screening for Down syndrome using nuchal translucency measurement with free beta-hCG and PAPP-A between 10 and 13 weeks of pregnancy – the combined test. Prenat Diagn 1999;19:360–3. PubMed PMID: 10327142
- Zhong Y, Tuuli M, Odibo A. First trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction. Prenat Diagn 2010;30:293–308
- Leung TY, Sahota DS, Chan LW, et al. Prediction of birth weight by fetal crownrump length and maternal serum levels of pregnancy-associated plasma protein-A in the first trimester. Ultrasound Obstet Gynecol 2008;31:10–14
- Velauthar L, Plana MN, Kalidindi, et al. First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55,974 women. Ultrasound Obstet Gynecol 2014;43:500–7
- Napolitano R, Rajakulasingam R, Memmo A, et al. Uterine artery Doppler screening for pre-eclampsia: comparison of the lower, mean and higher first-trimester pulsatility indices. Ultrasound Obstet Gynecol 2011;37:534–7
- Bakker M, Pajkrt E, Bilardo CM. Increased nuchal translucency with normal karyotype and anomaly scan: what next? Best Pract Res Clin Obstet Gynaecol 2014;28:355–66
- Gagnon A, Wilson RD, Audibert F, et al. Obstetrical complications associated with abnormal maternal serum marker analytes. J Obstet Gynaecol Canada 2008;30:918–49
- Carter EB, Goetzinger K, Tuuli MG, et al. Evaluating the optimal definition of abnormal first-trimester uterine artery Doppler parameters to predict adverse pregnancy outcomes. J Ultrasound Med 2015;34:1265–9
- Dugoff L, Cuckle HS, Hobbins JC, et al. FaSTER Trial Research Consortium. Prediction of patient-specific risk of fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome Markers. Am J Obstet Gynecol 2008;199:290
- Quattrocchi T, Baviera G, Pochiero T, et al. Maternal serum PAPP-A as an early marker of obstetric complications? Fetal Diagn Ther 2015;37:33–6